Cleared Traditional

K870381 - DD-VCR-64

K870381 is an FDA 510(k) clearance for DD-VCR-64, manufactured by Grass-Telefactor Product Group. The device is a Class 2 Neurology device with product code GWK cleared through the Traditional 510(k) pathway after a 55-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1987
Decision
55d
Days
Class 2
Risk

K870381 is an FDA 510(k) clearance for the DD-VCR-64. Classified as Conditioner, Signal, Physiological (product code GWK), Class II - Special Controls.

Submitted by Grass-Telefactor Product Group (W. Conshohocken, US). The FDA issued a Cleared decision on March 25, 1987 after a review of 55 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1845 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Grass-Telefactor Product Group devices

FDA 510(k) Submission Details - K870381

510(k) Number K870381 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 29, 1987
Decision Date March 25, 1987
Days to Decision 55 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
93d faster than avg
Panel avg: 148d · This submission: 55d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWK Device Classification - Class 2, Special Controls

Product Code GWK Conditioner, Signal, Physiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1845
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWK Conditioner, Signal, Physiological

All 13
Devices cleared under the same product code (GWK) and FDA review panel - the closest regulatory comparables to K870381.
MINI-LOGGER SERIES 2000
K991045 · Mini-Mitter Co., Inc. · Sep 1999
NEUROFILE DATA STORAGE/ACCESORIES TO THE EEG-4300
K905594 · Nihon Kohden America, Inc. · Jun 1991
BIO-LOGIC BANKER
K872290 · Bio-Logic Systems Corp. · Oct 1987
BRAIN FUNCTION MAPPING OPTION FOR PATHF
K843598 · Nicolet Biomedical Instruments · Apr 1985
NEUROPACK 8 MEE 4108
K841497 · Nihon Kohden America, Inc. · Jun 1984
NEUROTRAC
K841110 · Interspec, Inc. · Apr 1984